|
|
| Research article summary (published Aug 2008): |
Behavioral effects of the CRF1 receptor antagonist R121919 in rats selectively bred for high and low activity in the swim test.
Full Abstract
This study assessed effects of a CRF(1) receptor antagonist, R121919, on the behavior of rats that have been selectively bred to exhibit very high or very low activity in a swim test. Following treatment with R121919 (10 mg/kg, s.c.) or vehicle, several types of behavior were examined including: (1) spontaneous ambulatory activity in a novel environment, (2) swim-test activity, (3), and responses in an elevated plus maze. The most pronounced effects were observed in the swim test. Although R121919 had little effect on the swim-test behavior of normal, non-selected rats, Swim High-active rats (SwHi), characterized by being very active and exhibiting pronounced struggling behavior in the swim test, showed increased activity (more struggling) after R121919; in contrast, Swim Low-active (SwLo) rats, characterized by being very inactive and exhibiting pronounced floating behavior in the swim test, showed decreased activity (more floating) after R121919. This effect was observed in both male and female rats. No differences between strains or the effects of R121919 were observed for spontaneous ambulation or in the elevated plus maze test.
Author information
Author/s: Gutman, David A (DA); Coyer, Megan J (MJ); Boss-Williams, Katherine A (KA); Owens, Michael J (MJ); Nemeroff, Charles B (CB); Weiss, Jay M (JM);
Affiliation: Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 101 Woodruff Circle, Suite 4000 WMRB, Atlanta, GA 30322, United States. dagutman(-atsign-)gmail.com
Grants: MH42088 (Agency:NIMH NIH HHS) ; MH58922 (Agency:NIMH NIH HHS)
Journal and publication information
Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal: Psychoneuroendocrinology (Psychoneuroendocrinology), published in England. (Language: eng)
Reference: 2008-Sep; vol 33 (issue 8) : pp 1093-101
Dates: Created 2008/08/18; Completed 2008/12/09; Revised 2009/05/12;
PMID: 18676086, status: MEDLINE (last retrieved date: 5/12/2009)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
Comments and Corrections
ErratumIn: Psychoneuroendocrinology. 2009 May;34(4):630-1.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MeSH Headings (categories) shown below.
Note: Bold headings indicate primary MeSH headings or qualifiers.
Associated Chemicals: CRF receptor type 1 (0) ; Pyrimidines (0) ; R 121919 (0) ; Receptors, Corticotropin-Releasing Hormone (0)Related articles
These are the most related articles currently in our database:
- Blockade of corticoliberin receptors prevents the development of post-stress psychopathology in rats with an active strategy of adaptive behavior.
30 Jan 2008 - Increased depression-like behaviors in corticotropin-releasing factor receptor-2-deficient mice: sexually dichotomous responses.
13 Jun 2003 - Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat.
16 Oct 2002 - Anxiolytic-like effects of the corticotropin-releasing factor1 (CRF1) antagonist DMP904 [4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyrimidine] administered acutely or chronically at doses occupying central CRF1 receptors in rats.
21 Jan 2004 - Effects of CP 154,526, a CRF1 receptor antagonist, on behavioral responses to cocaine in rats.
31 Aug 2005 - 4-Aryl-2-anilinopyrimidines as corticotropin-releasing hormone (CRH) antagonists.
3 Apr 1999 - Altered serotonergic neurotransmission but normal hypothalamic-pituitary-adrenocortical axis activity in mice chronically treated with the corticotropin-releasing hormone receptor type 1 antagonist NBI 30775.
29 Nov 2003 - 2-Aryl-3,6-dialkyl-5-dialkylaminopyrimidin-4-ones as novel crf-1 receptor antagonists.
2 Aug 2003 - 3-Aryl pyrazolo[4,3-d]pyrimidine derivatives: Nonpeptide CRF-1 antagonists.
17 Aug 2002 - The high-affinity non-peptide CRH1 receptor antagonist R121919 attenuates stress-induced alterations in plasma oxytocin, prolactin, and testosterone secretion in rats.
30 Dec 2002
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a larger map of 100+ related articles.